351. Validation of a new objective method to assess lipid layer thickness without the need of an interferometer
- Author
-
Alejandro Cerviño, Cristian Talens-Estarelles, José Vicente García-Marqués, and Santiago García-Lázaro
- Subjects
Image processing ,Tear film ,Correlation ,Cellular and Molecular Neuroscience ,Lipid layer thickness ,Pathology ,High-speed videokeratoscopy ,Humans ,Sensitivity (control systems) ,Dry eye disease ,Mathematics ,Receiver operating characteristic ,business.industry ,Meibomian gland dysfunction ,Meibomian Glands ,Pattern recognition ,Repeatability ,Lipids ,Sensory Systems ,Intensity (physics) ,Ophthalmology ,Interferometry ,Tears ,Dry Eye Syndromes ,Artificial intelligence ,business - Abstract
Purpose This study aimed to develop and validate new metrics to objectively assess the lipid layer thickness (LLT) through the analysis of grey intensity values obtained from the Placido disk pattern reflected onto the tear film. Methods Ocular surface parameters were measured using Oculus Keratograph 5 M in 94 healthy volunteers (43.8 ± 26.8 years). Subjects’ LLT was subjectively classified into 4 groups using an interferometry-based grading scale. New metrics based on the intensity of the Placido disk images were calculated and compared between groups. The repeatability of the new metrics and their diagnostic ability was analysed through receiver operating characteristics (ROC) curves. The level of agreement between the new objective tool and the existing subjective classification scale was analysed by means accuracy, weighted Kappa index and F-measure. Results Mean pixel intensity, median pixel intensity and relative energy at 5.33 s after blinking achieved the highest performance, with a correlation with LLT between r = 0.655 and 0.674 (p F-measure between 0.86 and 0.87. Conclusion The analysis of grey intensity values in videokeratography can be used as an objective tool to assess LLT. These new metrics could be included in a battery of clinical tests as an easy, repeatable, objective and accessible method to improve the detection and monitoring of dry eye disease and meibomian gland dysfunction.
- Published
- 2021